# Relay Therapeutics, Inc.: Form 8-K, filed Sep 11, 2024

- Company: [Relay Therapeutics, Inc.](/companies/rlay.md) (CIK 1812364)
- Form: 8-K
- Filed: 2024-09-11
- Accepted by EDGAR: Sep 11, 2024, 16:49 ET
- Period: 2024-09-09
- Accession: 0001193125-24-217296
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1812364/000119312524217296/d892276d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1812364/000119312524217296/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1812364/000119312524217296/d892276d8k.htm

Filed Sep 11, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-217296. Last ingested by Listed: Nov 4, 2026, 17:16 ET. No prices; not investment advice.